LAB Q3 2018 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q3 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$29M+17.0% YoY

Gross Profit

$16M54.6% margin

Operating Income

-$12M-40.1% margin

Net Income

-$15M-50.9% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$252M

Total Liabilities

$230M

Stockholders' Equity

$22M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$25M	+17.0%
Gross Profit	$16M	$12M	+29.9%
Operating Income	-$12M	-$16M	+25.5%
Net Income	-$15M	-$16M	+7.5%

Revenue Segments

Total Products

$24M46%

Instruments

$14M26%

Consumables

$10M19%

Service

$5M9%

Geographic Segments

UNITED STATES

$13M46%

Europe

$9M30%

Asia Pacific

$7M23%

Other Geographical Countries

$421,0001%